[1] TIAN C J, ZHEN Z. Reactive carbonyl species: diabetic complication in the heart and lungs[J]. Trends Endocrinol Metab,2019,30(8):546-556. doi:  10.1016/j.tem.2019.05.005
[2] KOPF S, KUMAR V, KENDER Z, et al. Diabetic pneumopathy-A new diabetes-associated complication: mechanisms, consequences and treatment considerations[J]. Front Endocrinol (Lausanne),2021,12:765201. doi:  10.3389/fendo.2021.765201
[3] MOZZANICA F, FERRULLI A, VUJOSEVIC S, et al. Olfactory disfunction and diabetic complications in type 2 diabetic patients: a pilot study[J]. Endocrine,2022,75(3):760-767. doi:  10.1007/s12020-021-02897-6
[4] WU L, LIU C J, CHANG D Y, et al. Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy[J]. Kidney Int,2021,100(1):107-121. doi:  10.1016/j.kint.2021.02.025
[5] KAZAMEL M, STINO A M, SMITH A G. Metabolic syndrome and peripheral neuropathy[J]. Muscle Nerve,2021,63(3):285-293. doi:  10.1002/mus.27086
[6] HASHIM N A, ARIARATNAM S, SALLEH M R, et al. Depression and associated factors in patients with type 2 diabetes mellitus[J]. East Asian Arch Psychiatry,2016,26(2):77-82.
[7] SEMENKOVICH K, BROWN M E, SVRAKIC D M, et al. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment[J]. Drugs,2015,75(6):577-587. doi:  10.1007/s40265-015-0347-4
[8] CAMPAYO A, DE JONGE P, ROY J F, et al. Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression[J]. Am J Psychiatry,2010,167(5):580-588. doi:  10.1176/appi.ajp.2009.09010038
[9] ZHANG J T, WU C C, SHENG J Y, et al. Molecular basis of 5-hydroxytryptophan synthesis in Saccharomyces cerevisiae[J]. Mol Biosyst,2016,12(5):1432-1435. doi:  10.1039/C5MB00888C
[10] NAKHLEH M K, AMAL H, JERIES R, et al. Diagnosis and classification of 17 diseases from 1404 subjects via pattern analysis of exhaled molecules[J]. ACS Nano,2017,11(1):112-125. doi:  10.1021/acsnano.6b04930
[11] BROZA Y Y, VISHINKIN R, BARASH O, et al. Synergy between nanomaterials and volatile organic compounds for non-invasive medical evaluation[J]. Chem Soc Rev,2018,47(13):4781-4859. doi:  10.1039/C8CS00317C
[12] DIETER T, LAUERER J. Depression or diabetes distress? Perspect Psychiatr Care,2018,54(1):84-87. doi:  10.1111/ppc.12203
[13] WU W W, HAICK H. Materials and wearable devices for autonomous monitoring of physiological markers[J]. Adv Mater,2018,30(41):e1705024. doi:  10.1002/adma.201705024
[14] BOGNER H R, MCCLINTOCK H F. Costs of coexisting depression and diabetes[J]. J Gen Intern Med,2016,31(6):594-595. doi:  10.1007/s11606-016-3675-5
[15] CHEN S G, ZHANG Q, DAI G X, et al. Association of depression with pre-diabetes, undiagnosed diabetes, and previously diagnosed diabetes: a meta-analysis[J]. Endocrine,2016,53(1):35-46. doi:  10.1007/s12020-016-0869-x
[16] BOT M, POUWER F, ZUIDERSMA M, et al. Association of coexisting diabetes and depression with mortality after myocardial infarction[J]. Diabetes Care,2012,35(3):503-509. doi:  10.2337/dc11-1749
[17] WOOLLAM M, TELI M, ANGARITA-RIVERA P, et al. Detection of volatile organic compounds (VOCs) in urine via gas chromatography-mass spectrometry QTOF to differentiate between localized and metastatic models of breast cancer[J]. Sci Rep,2019,9(1):2526. doi:  10.1038/s41598-019-38920-0
[18] DA COSTA B R B, DE MARTINIS B S. Analysis of urinary VOCs using mass spectrometric methods to diagnose cancer: a review[J]. Clin Mass Spectrom,2020,18:27-37. doi:  10.1016/j.clinms.2020.10.004
[19] DAULTON E, WICAKSONO A N, TIELE A, et al. Volatile organic compounds (VOCs) for the non-invasive detection of pancreatic cancer from urine[J]. Talanta,2021,221:121604. doi:  10.1016/j.talanta.2020.121604
[20] ESFAHANI S, WICAKSONO A, MOZDIAK E, et al. Non-invasive diagnosis of diabetes by volatile organic compounds in urine using FAIMS and Fox4000 electronic nose[J]. Biosensors (Basel),2018,8(4):E121.